Loretta J. Nastoupil

The University of Texas MD Anderson Cancer Center

Also affiliated with Southwest Women's Oncology

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 2%percentile

3.1Author DataRank

Indexed papers

3in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes

American Journal of Hematology(2024)10.1002/ajh.27202

Top 10%

2.1DataRank

Top 10%24 citations

Matthew J. Maurer, Brian K. Link, Andrew L. Feldman, Thomas M. Habermann, David L. Jaye +38 more

Papers

Driven by 50 papers — median percentile 79. Top paper: “Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial”.

Safety, efficacy and determinants of response of allogeneic CD19-specific CAR-NK cells in CD19+ B cell tumors: a phase 1/2 trial

Nature Medicine(2024)10.1038/s41591-023-02785-8

N/A

4.0DataRank · unranked

468 citations

Ye Li, Rafet Başar, Hind Rafei, May Daher, Jinzhuang Dou +31 more

Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma

Blood Cancer Discovery(2022)10.1158/2643-3230.bcd-21-0177

N/A

3.4DataRank · unranked

75 citations

David M. Swoboda, Uri Greenbaum, Junsheng Ma, Romil Patel, Kartik Devashish +34 more

The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes

American Journal of Hematology(2024)10.1002/ajh.27202

Top 10%

2.1DataRank

Top 10%24 citations

Matthew J. Maurer, Brian K. Link, Andrew L. Feldman, Thomas M. Habermann, David L. Jaye +38 more

Smart Start: Rituximab, Lenalidomide, and Ibrutinib in Patients With Newly Diagnosed Large B-Cell Lymphoma

Journal of Clinical Oncology(2022)10.1200/jco.22.00597

N/A

1.7DataRank · unranked

58 citations

R. Eric Davis, Lei Feng, Fredrick B. Hagemeister, Raphaël Steiner, Hun Ju Lee +24 more

Ibrutinib–rituximab followed by R-HCVAD as frontline treatment for young patients (≤65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial

The Lancet Oncology(2022)10.1016/s1470-2045(21)00638-0

N/A

1.5DataRank · unranked

56 citations

Preetesh Jain, Shuangtao Zhao, Hun Ju Lee, Loretta J. Nastoupil, Luis Fayad +32 more

Safety and activity of pembrolizumab in combination with rituximab in relapsed or refractory follicular lymphoma

Blood Advances(2022)10.1182/bloodadvances.2021006240

N/A

1.4DataRank · unranked

47 citations

Collin K. Chin, Jason R. Westin, Nathan Fowler, Felipe Samaniego, Xiaoyun Cheng +12 more

Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium

Journal of Clinical Oncology(2020)10.1200/jco.19.02104

N/A

1.0DataRank · unranked

800 citations

Michael D. Jain, Lei Feng, Jay Y. Spiegel, Armin Ghobadi, Yi Lin +23 more

A single-cell atlas of CD19 chimeric antigen receptor T cells

Cancer Cell(2023)10.1016/j.ccell.2023.08.015

Top 21%

0.969DataRank

Top 21%24 citations

Jared Henderson, Max J. Gordon, Irtiza Sheikh, Loretta J. Nastoupil, Jason R. Westin +8 more

Axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma patients in complete metabolic response

Haematologica(2022)10.3324/haematol.2022.281954

N/A

0.822DataRank · unranked

15 citations

Sushanth Gouni, Jason R. Westin, Lei Feng, Haleigh Mistry, Raphaël Steiner +16 more

Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium

Journal of Clinical Oncology(2024)10.1200/jco.23.02786

N/A

0.650DataRank · unranked

75 citations

Jay Y. Spiegel, Loretta J. Nastoupil, John Tamaresis, Armin Ghobadi, Yi Lin +27 more

A phase 1/2 study of lenalidomide and obinutuzumab with CHOP for newly diagnosed DLBCL

Blood Advances(2022)10.1182/bloodadvances.2022008174

N/A

0.629DataRank · unranked

15 citations

Stefan Alig, Yasuhiro Oki, Loretta J. Nastoupil, Luis Fayad, Sattva S. Neelapu +16 more

Optimizing the post-CAR T monitoring period in recipients of axicabtagene ciloleucel, tisagenlecleucel, and lisocabtagene maraleucel

Blood Advances(2024)10.1182/bloodadvances.2023012549

N/A

0.533DataRank · unranked

34 citations

William Wesson, Forat Lutfi, David L. Porter, Veronika Bachanová, Loretta J. Nastoupil +11 more

Prognostic impact of dose, duration, and timing of corticosteroid therapy in patients with large B-cell lymphoma treated with standard of care axicabtagene ciloleucel (Axi-cel).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.8011

N/A

0.470DataRank · unranked

22 citations

Fateeha Furqan, Jason R. Westin, Luis Fayad, Sairah Ahmed, Hun Ju Lee +15 more

Vitamin D in patients with low tumor-burden indolent non-Hodgkin lymphoma treated with rituximab therapy (ILyAD): a randomized, phase 3 clinical trial

EClinicalMedicine(2024)10.1016/j.eclinm.2024.102959

N/A

0.465DataRank · unranked

9 citations

Michael T. Brady, Myla Strawderman, Brad S. Kahl, Izidore S. Lossos, Jonathon B. Cohen +13 more

Outcomes of Relapsed or Refractory Diffuse Large B‐Cell Lymphoma Treated With R‐GemOx: A Multicenter Cohort Study

American Journal of Hematology(2025)10.1002/ajh.27630

N/A

0.409DataRank · unranked

10 citations

Jean L. Koff, Melissa C. Larson, Brad S. Kahl, Carla Casulo, Izidore S. Lossos +25 more

Cytokine Storms in COVID-19, Hemophagocytic Lymphohistiocytosis, and CAR-T Therapy

JAMA Network Open(2025)10.1001/jamanetworkopen.2025.3455

N/A

0.373DataRank · unranked

11 citations

Rishab Prakash, Paul Edelkamp, Mark Knafl, Anath C. Lionel, Ranjit Nair +94 more

Partial omission of bleomycin for early‐stage Hodgkin lymphoma patients treated with combined modality therapy: Does incomplete ABVD lead to inferior outcomes?

eJHaem(2020)10.1002/jha2.1

N/A

0.292DataRank · unranked

6 citations

Chelsea C. Pinnix, Gordon Glober, Kaitlin M. Christopherson, Penny Fang, Hun Ju Lee +8 more

Effect of delayed cell infusion in patients with large B-cell lymphoma treated with chimeric antigen receptor T-cell therapy

Haematologica(2023)10.3324/haematol.2023.284453

N/A

0.284DataRank · unranked

4 citations

Naishu Kui, Ryan Sun, Jason R. Westin, Raphaël Steiner, Ranjit Nair +16 more

A phase 2 study of obinutuzumab combined with lenalidomide in previously untreated high tumor burden follicular lymphoma

Blood Advances(2025)10.1182/bloodadvances.2025016483

N/A

0.241DataRank · unranked

4 citations

Lei Feng, Jason R. Westin, Fredrick B. Hagemeister, Hun Ju Lee, Luis Fayad +16 more

Early-Stage Extranodal NK/T-Cell Lymphoma, Nasal Type: A Role for Elective Nodal Irradiation?

Advances in Radiation Oncology(2024)10.1016/j.adro.2024.101650

N/A

0.104DataRank · unranked

1 citations

Sonal S. Noticewala, Susan Wu, Jillian R. Gunther, Ethan B. Ludmir, L. Jeffrey Medeiros +15 more

Therapy for patients with POD24 follicular lymphoma: Treatment patterns and outcomes from the Lymphoma Epidemiology of Outcomes (LEO) Consortium.

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.7573

N/A

0.104DataRank · unranked

1 citations

Melissa C. Larson, Jonathan R Day, Thomas M. Habermann, Izidore S. Lossos, Yucai Wang +15 more

Defining primary refractory large B-cell lymphoma

Blood Advances(2024)10.1182/bloodadvances.2024012760

N/A

0DataRank · unranked

32 citations

Raphael Mwangi, Yucai Wang, Arushi Khurana, Matthew J. Maurer, Amy Ayers +15 more

Lisocabtagene maraleucel for relapsed/refractory large B-cell lymphoma: a cell therapy consortium real-world analysis

Blood Advances(2024)10.1182/bloodadvances.2024014164

N/A

0DataRank · unranked

24 citations

Connor B. Grady, Loretta J. Nastoupil, Alejandro Luna, Nausheen Ahmed, Richard T. Maziarz +12 more

Outcomes of CD19 CAR T in Transformed Indolent Lymphoma Compared to De Novo Aggressive Large B‐Cell Lymphoma

American Journal of Hematology(2024)10.1002/ajh.27548

N/A

0DataRank · unranked

13 citations

Reid W. Merryman, Yan Wang, Charles Gaulin, Evandro D. Bezerra, Timothy Voorhees +16 more

Real-world impact of differences in the WHO and ICC classifications of non-Hodgkin lymphoma: a LEO cohort study analysis

Blood(2024)10.1182/blood.2024025681

N/A

0DataRank · unranked

5 citations

Matthew J. Maurer, Thomas M. Habermann, Richard Burack, Jennifer R. Chapman, Jonathon B. Cohen +18 more

Impact of patient demographics and neighborhood socioeconomic variables on clinical trial participation patterns for NHL

Blood Advances(2024)10.1182/bloodadvances.2023011040

N/A

0DataRank · unranked

6 citations

Clark R. Andersen, Amy Ayers, Jason R. Westin, Michael Wang, Swaminathan P. Iyer +10 more

Impact of Pre-Treatment Liver-Related Factors on Clinical Outcomes after CAR T-Cell Therapy for Lymphoma

Blood(2024)10.1182/blood-2024-207616

N/A

0DataRank · unranked

1 citations

Sushanth Gouni, Lei Feng, Charles Gaulin, Amrit S. Gonugunta, Turçin Saridogan +22 more

Consensus recommendations from the 2024 International Follicular Lymphoma Scientific Workshop

Blood Advances(2025)10.1182/bloodadvances.2025018079

N/A

0DataRank · unranked

3 citations

Sarah C. Rutherford, Stephen M. Ansell, Philippe Armand, John P. Leonard, Loretta J. Nastoupil +20 more

Pharmacokinetics of KA2237, a novel selective inhibitor of PI3K-β and PI3K-δ, in patients: A first-in-human study using PK modelling to predict drug concentrations during dose escalation

(2021)10.22541/au.162460492.29738849/v1

N/A

0DataRank · unranked

0 citations

Graham Trevitt, Elisabeth Bone, Kemal Haque, Loretta Nastoupil, Elisabeth A. Bone +2 more

FLIPI24: A Modern Prognostic Model and Clinical Trial Enrichment Tool for Newly Diagnosed Follicular Lymphoma

Journal of Clinical Oncology(2025)10.1200/jco-25-00892

N/A

0DataRank · unranked

1 citations

Vít Procházka, Tarec Christoffer El‐Galaly, Christopher R. Flowers, Diego Villa, Emmanuel Bachy +43 more

Clinical efficacy of anakinra to mitigate CAR T-cell therapy–associated toxicity in large B-cell lymphoma

Blood Advances(2020)10.1182/bloodadvances.2020002328

N/A

0DataRank · unranked

197 citations

Sairah Ahmed, Partow Kebriaei, Loretta J. Nastoupil, Catherine M. Claussen, Grace Watson +10 more

Selective Inhibition of HDAC3 Targets Synthetic Vulnerabilities and Activates Immune Surveillance in Lymphoma

Cancer Discovery(2020)10.1158/2159-8290.cd-19-0116

N/A

0DataRank · unranked

159 citations

Saber Tadros, Matt Teater, Lorena Fontán, Aaron Y. Chang, Neeraj Jain +24 more

Assessment of Radiation Doses Delivered to Organs at Risk Among Patients With Early-Stage Favorable Hodgkin Lymphoma Treated With Contemporary Radiation Therapy

JAMA Network Open(2020)10.1001/jamanetworkopen.2020.13935

N/A

0DataRank · unranked

12 citations

Jillian R. Gunther, Penny Fang, Mikaela Bankston, Sarah A. Milgrom, David Boyce-Fappiano +14 more

Imaging Surveillance of Limited-stage Classic Hodgkin Lymphoma Patients After PET–CT-documented First Remission

Clinical Lymphoma Myeloma & Leukemia(2020)10.1016/j.clml.2020.02.008

N/A

0DataRank · unranked

5 citations

Jillian R. Gunther, Penny Fang, Sarah A. Milgrom, Brinda Rao Korivi, Corey T. Jensen +16 more

Radiation and CAR T-cell Therapy in Lymphoma: Future Frontiers and Potential Opportunities for Synergy

Frontiers in Oncology(2021)10.3389/fonc.2021.648655

N/A

0DataRank · unranked

37 citations

Jillian R. Gunther, Susan Wu, Bouthaina S. Dabaja, Loretta J. Nastoupil, Sairah Ahmed +3 more

Nine-Year Follow-up of Patients with Relapsed Follicular Lymphoma after Nonmyeloablative Allogeneic Stem Cell Transplant and Autologous Transplant

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-21-1377

N/A

0DataRank · unranked

7 citations

Denái R. Milton, Alison Gulbis, Elias Jabbour, Loretta J. Nastoupil, Celina Ledesma +16 more

CARDIOVASCULAR EVENTS AMONG ADULT PATIENTS WITH AGGRESSIVE B‐CELL LYMPHOMA TREATED WITH STANDARD OF CARE AXICABTAGENE CILOLEUCEL AND TISAGENLECLEUCEL

Hematological Oncology(2021)10.1002/hon.177_2880

N/A

0DataRank · unranked

0 citations

José Banchs, Efstratios Koutroumpakis, Melody Becnel, Cristina Gutiérrez, Paolo Strati +14 more

Clonal hematopoiesis is associated with increased toxicity in large B-cell lymphoma patients treated with chimeric antigen receptor T cell therapy

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.09.28.461858

N/A

0DataRank · unranked

0 citations

David M. Swoboda, Uri Greenbaum, Jungsheng Ma, Romil Patel, Kartik Devashish +32 more

Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion

Nature Reviews Clinical Oncology(2022)10.1038/s41571-022-00607-3

N/A

0DataRank · unranked

330 citations

Sara Silbert, Shannon L. Maude, Loretta J. Nastoupil, Carlos A. Ramos, Renier J. Brentjens +4 more

Early drug development in solid tumours: analysis of National Cancer Institute-sponsored phase 1 trials

The Lancet(2022)10.1016/s0140-6736(22)01390-3

N/A

0DataRank · unranked

68 citations

Ruitao Lin, Christopher R. Flowers, Shanda Finnigan, Lisa M. Cordes, Yoko Fukuda +7 more

Treatment patterns and outcomes of patients with relapsed or refractory follicular lymphoma receiving three or more lines of systemic therapy (LEO CReWE): a multicentre cohort study

The Lancet Haematology(2022)10.1016/s2352-3026(22)00033-3

N/A

0DataRank · unranked

64 citations

Melissa C. Larson, Julianne J. Lunde, Thomas M. Habermann, Izidore S. Lossos, Yucai Wang +19 more

Low toxicity and excellent outcomes in patients with DLBCL without residual lymphoma at the time of CD19 CAR T-cell therapy

Blood Advances(2022)10.1182/bloodadvances.2022008294

N/A

0DataRank · unranked

42 citations

Ana Alarcón Tomás, Jessica Flynn, Sean M. Devlin, Jamie Brower, Veronika Bachanová +10 more

Chimeric antigen receptor T-cell therapy yields similar outcomes in patients with and without cytokine release syndrome

Blood Advances(2022)10.1182/bloodadvances.2022008937

N/A

0DataRank · unranked

20 citations

Vivek Patel, David L. Porter, Stephen J. Schuster, Loretta J. Nastoupil, Miguel‐Angel Perales +10 more

Tafasitamab and lenalidomide in large B-cell lymphoma: real-world outcomes in a multicenter retrospective study

Blood(2023)10.1182/blood.2023021274

N/A

0DataRank · unranked

47 citations

Nicholas Lambert, Paolo F. Caimi, Mwanasha H. Merrill, Priyanka Pullarkat, Richard Godby +19 more

A phase 1 study of prophylactic anakinra to mitigate ICANS in patients with large B-cell lymphoma

Blood Advances(2023)10.1182/bloodadvances.2023010653

N/A

0DataRank · unranked

44 citations

Andrew Jallouk, Qing Deng, Xubin Li, Lei Feng, Ryan Sun +23 more

Identifying an optimal fludarabine exposure for improved outcomes after axi-cel therapy for aggressive B-cell non-Hodgkin lymphoma

Blood Advances(2023)10.1182/bloodadvances.2023010302

N/A

0DataRank · unranked

35 citations

Jessica Flynn, Mithat Gönen, Sean M. Devlin, Allison Parascondola, Ana Alarcón Tomás +17 more

Bridging therapy with axicabtagene ciloleucel for large B-cell lymphoma: results from the US Lymphoma CAR-T Consortium

Blood Advances(2023)10.1182/bloodadvances.2023011489

N/A

0DataRank · unranked

26 citations

Miriam T. Jacobs, Feng Gao, Loretta J. Nastoupil, Jay Y. Spiegel, Yi Lin +21 more

Six Years Follow up of Ibrutinib Plus Rituximab (IR) Followed By Short Course R-Hyper CVAD/MTX in Patients (age ≤ 65 years) with Previously Untreated Mantle Cell Lymphoma - Phase-II Window-1 Clinical Trial

Blood(2023)10.1182/blood-2023-181312

N/A

0DataRank · unranked

1 citations

Hun Ju Lee, Jason R. Westin, Loretta J. Nastoupil, Luis Fayad, Ranjit Nair +14 more

Data from Follicular Lymphoma Microenvironment Characteristics Associated with Tumor Cell Mutations and MHC Class II Expression

(2023)10.1158/2643-3230.c.6550995

Top 100%

0DataRank

Top 100%0 citations

Qing Deng, Mario L. Marques‐Piubelli, Enyu Dai, Minghao Dang, Man Chun John +29 more

Data from Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma

(2023)10.1158/2643-3230.c.6550812.v1

N/A

0DataRank · unranked

0 citations

David M. Swoboda, Uri Greenbaum, Junsheng Ma, Romil Patel, Kartik Devashish +34 more

Loretta J. Nastoupil

Indexed papers

Top data-sharing exemplar

Papers